Logo for Vaxart Inc

Vaxart Investor Relations Material

Latest events

Logo for Vaxart Inc

Study Result

Vaxart
Logo for Vaxart

Study Result

11 Jun, 2025
Logo for Vaxart

Q1 2025

13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Vaxart Inc

Access all reports
Vaxart Inc. is a biotechnology company focused on developing oral vaccines that are administered using tablet formulations rather than injections. The company's proprietary oral vaccine platform is designed to stimulate immune responses in mucosal tissues, which are the first line of defense against many infections. Vaxart's vaccine candidates target a range of infectious diseases, including influenza, norovirus, and COVID-19. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.